Driehaus Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$6.31M Sell
2024
Q1
$6.42M Sell
2023
Q4
$12.6M Sell
2023
Q3
$9.96M Sell
2023
Q2
$9.32M Buy
2023
Q1
$7.98M Buy
2022
Q4
$6.84M Buy
2022
Q3
$7.68M Buy
2021
Q1
Sell
2020
Q4
$950K Buy